ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2023

News provided by

Apr 05, 2023, 03:39 ET

GOTHENBURG, Sweden, April 5, 2023 /PRNewswire/ -- Zinzino group revenue increased with a total of 18% in Q1 compared with the previous year.

The revenue in March for Zinzino's sales markets increased by 13% and amounted to SEK 135.4 (119.5) million. Faun Pharma's external sales were unchanged and amounted to SEK 9.9 (9.9) million. Overall, the Group increased revenues by 12% to SEK 145.3 (129.4) million compared with the previous year.

The group revenue increased with 18% for Q1 2023 compared with the first quarter last year and amounted to SEK 393.0 (334.4) million.

Revenues were distributed as follows:

Regions, mSEK	23-mar	22-mar	Change	Q1 2023	Q1 2022	Change
The Nordics	26.0	32.8	-21 %	72.8	80.3	-9 %
Central Europe	35.4	22.2	59 %	90.8	59.1	54 %
East Europe	34.6	31.5	10 %	92.6	83.4	11 %
South & West Europe	18.7	14.3	31 %	49.0	38.1	29 %
The Baltics	7.7	6.7	15 %	21.1	18.3	15 %
North America	7.1	5.4	31 %	19.6	14.1	39 %
Asia-Pacific	4.5	6.1	-26 %	15.6	16.4	-5 %
Africa	1.4	0.5	180 %	3.8	1.4	171 %
Zinzino	135.4	119.5	13 %	365.3	311.1	17 %
Faun Pharma	9.9	9.9	0 %	27.7	23.3	19 %
Zinzino Group	145.3	129.4	12 %	393.0	334.4	18 %

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
Africa: South Africa